Biocryst Pharmaceuticals Inc
BCRX
$11.04+0.06 (+0.55%)
Jun 7, 2025, 4:00 PM
Financials
| 52Week High | 11.31 | 52Week Low | 5.92 |
| Beta | 1.21 | Current Ratio Annual | 2.63 |
| Current Ratio Quarterly | 2.93 | Gross Margin TTM | 96.89 |
| Market Cap | 2.31B | Net Profit Margin TTM | -10.62 |
| Operating Margin TTM | 6.59 | Price To Book | 68.75 |
| Price To Free Cash Flow TTM | 282.20 | Price To Sales TTM | 4.59 |
| Quick Ratio Annual | 2.49 | Quick Ratio Quarterly | 2.78 |
| Return On Assets TTM | -11.06 | Return On Equity TTM | -328.82 |
| Return On Investment TTM | -106.66 | Revenue Growth3Y | 42.06 |
| Revenue Growth5Y | 55.99 | Revenue Growth Quarterly Yoy | 56.89 |
| Revenue Growth TTMYoy | 41.67 | Revenue Per Share TTM | 2.34 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 259 | 1 | 1 | 2 | 3 | 1 | 169.32M | $1.23B |
| Mar 31, 2025 | 267 | 35 | 26 | 110 | 65 | 49 | 175.23M | $1.27B |
| Change | 8(3%) | 34(3400%) | 25(2500%) | 108(5400%) | 62(2067%) | 48(4800%) | 5.91M(3%) | $40.64M(3%) |